Two metastatic melanoma patients underwent [18F]CFA-PET/computed tomography (CT) before and 2–4 weeks after the onset of combined CIT (anti-PD1 mAb + anti-CTLA4 mAb). This evidence concerns the gene CTLA4 and metastatic melanoma.